The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Understand the key factors for determining when to sell stocks and buy bonds to optimize your investment strategy.
28,656 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
As markets swing in 2026, savers confront whether their 401(k) targets match reality. This report breaks down age-by-...
A sweeping housing proposal could unlock an easier path to ownership for many Americans. This guide breaks down what ...
A Boring Company tunneling site in Las Vegas was paused after a worker sustained a crushing injury as regulators inve...
As 2026 unfolds, retirees face tax and market challenges. A seasoned advisor outlines a tax-smart playbook for a $2 m...
Three AI ETFs—CHAT, IGPT, and WISE—have consistently surfaced as thoughtful ways to own the generative AI theme, each...
Chinese beauty brands flock to Southeast Asia as Joy Group expands from Singapore into Malaysia, marking a strategic ...
Retirees who claimed social security here’s at 62 may still see bigger monthly checks later, thanks to a do-over rule...
Arianna Huffington doesn’t believe true work-life balance exists, opting for a strict end-of-day boundary by charging...
Micah Lasher won a crowded Democratic primary in Manhattan, delivering a setback to the Kennedy legacy. The race also...
As deposit wars heat up in 2026, this report weighs the real value of chasing checking account bonuses worth the effo...
OpenUSD, backed by Visa, Mastercard and more, challenges Circle's stablecoin dominance. Analysts debate whether Circl...